Chinese Company Says Its COVID-19 Vaccine Should Be Available in U.S. in Early 2021
If it passes final round of human tests, SinoVac will apply to the FDA to sell CoronaVac vaccine
United First U.S. Airline to Offer COVID-19 Testing for Passengers
Rapid test at airport provides results in about 20 minutes and will cost $250
Public Awareness Low for Invasive Fungal Diseases
Awareness varies from 4.1 percent for blastomycosis to 24.6 percent for candidiasis
Most People With SARS-CoV-2 Do Not Remain Asymptomatic
Secondary attack rate lower for contacts of people with asymptomatic versus symptomatic infection
Negative Pressure Does Not Cut C-Section Infection Risk in Obese
Findings do not support routine use of prophylactic negative pressure wound therapy in obese women
Red Blood Cell Distribution Width, Mortality Tied in COVID-19
Elevated RDW and increase in RDW during hospitalization linked to increased mortality risk
SARS-CoV-2 Mortality Mainly Linked to Older Age, Comorbidity
Among U.S. veterans, obesity, Black race, Hispanic ethnicity, COPD, HTN not tied to COVID-19 mortality
Stricter Vaccine Approval Rules Coming From FDA
If approved by the White House, revised guidelines could be released as early as next week
J&J COVID-19 Vaccine Begins Final Stage of Clinical Trials
Phase 3 trials will include 60,000 people and be the largest for a COVID-19 vaccine in the United States
U.S. COVID-19 Death Toll Hits 200,000 as Cases Climb in 22 States
IHME says COVID-19 is second-leading cause of death in the United States, after heart disease
